The sales were disclosed in an SEC filing and reported pursuant to a Rule 10b5-1 trading plan, the report said.
Mr. Miles’ stock sale comes just over a month after the company reported $177 million second quarter revenue, a 39 percent increase year-over-year. The company also saw a banner year in 2022 with a 44 percent revenue jump.
This year, Alphatec is expecting its 2023 revenue to grow 32 percent year-over-year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
